Published in TB and Outbreaks Week, July 1st, 2003
As part of this pioneering effort, Lilly will:
1) Transfer its technology to manufacture two antibiotics necessary for treatment of MDR-TB to nations where the disease is most prevalent;
2) Establish a Center...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.